Myomo, Inc. (MYO)
Automate Your Wheel Strategy on MYO
With Tiblio's Option Bot, you can configure your own wheel strategy including MYO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MYO
- Rev/Share 0.9318
- Book/Share 0.5232
- PB 5.5051
- Debt/Equity 0.3814
- CurrentRatio 2.6635
- ROIC -0.2101
- MktCap 103619232.0
- FreeCF/Share -0.085
- PFCF -29.4232
- PE -20.5377
- Debt/Assets 0.2024
- DivYield 0
- ROE -0.3557
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral
Myomo, Inc. (NYSE:MYO ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, Investor Relations Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig-Hallum Scott Henry - Alliance Global Partners Anthony Vendetti - Maxim Group Sean Lee - H.C. Wainwright Edward Woo - Ascendiant Capital Operator Good afternoon, and welcome to the Myomo's First Quarter 2025 Earnings Conference Call.
Read More
Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
Myomo, Inc. (MYO) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.10 per share a year ago.
Read More
Myomo Reports First Quarter 2025 Financial and Operating Results
Published: May 07, 2025 by: Business Wire
Sentiment: Neutral
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2025. Financial and operating highlights for the first quarter of 2025 include the following (all comparisons are with the first quarter of 2024 unless otherwise indicated): Revenue was.
Read More
Myomo to Host Investor & Analyst Day Event on June 18, 2025
Published: May 01, 2025 by: Business Wire
Sentiment: Neutral
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the Company will be hosting its first-ever Investor & Analyst Day event on Wednesday, June 18, 2025. The event will take place at Myomo's new corporate headquarters and manufacturing facility in Burlington, Mass., and will offer an in-depth l.
Read More
About Myomo, Inc. (MYO)
- IPO Date 2017-06-12
- Website https://www.myomo.com
- Industry Medical - Devices
- CEO Mr. Paul R. Gudonis
- Employees 184